2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

ESC Scientific Document Group, Alexander R. Lyon*, Teresa López-Fernánde*, Liam S. Couch, Riccardo Asteggiano, Marianne C. Aznar, Jutta Bergler-Klei, Giuseppe Boriani, Daniela Cardinale, Raul Cordoba, Bernard Cosyns, David J. Cutter, Evandro De Azambuja, Rudolf A. De Boer, Susan F. Dent, Dimitrios Farmakis, Sofie A. Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel LenihanJavid Moslehi, Brenda Moura, Sonja S. Salinger, Richard Stephens, Thomas M. Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter Van Der Meer, Helena J.H. Van Der Pal, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe Aleman, Joachim Alexandre, Ana Barac, Michael A. Borger, Ruben Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkiene, Maja Cikes, Alain Cohen-Solal, Kreena Dhiman, Thor Edvardsen, Laurent Fauchier, Michael Fradley, Julia Grapsa, Sigrun Halvorsen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

858 Citations (Scopus)
Original languageEnglish
Pages (from-to)4229-4361
Number of pages133
JournalEuropean Heart Journal
Volume43
Issue number41
DOIs
Publication statusPublished - 1 Nov 2022

Bibliographical note

Funding Information:
ESC and updated. The Task Force received its entire financial support from the ESC without any involvement from the healthcare industry.

Cite this